Sanofi has announced that it will be expanding its immunology capabilities by acquiring US-based Blueprint Medicines ...

Lilly’s Omvoh is already recommended by NICE to treat certain cases of ulcerative colitis, another of the two main forms of ...

While sounding like an obvious statement, strategic planning is pivotal in shaping long-term success. However, given the lack ...

Pfizer has shared positive survival results from a late-stage study of its Braftovi (encorafenib) regimen in patients with ...

The key to success lies in striking the right balance: leveraging AI’s capabilities while maintaining the human elements that ...

Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on ...

Results presented at this year’s American Thoracic Society International Conference showed that the trials met their primary ...

Sanofi has announced that it will be acquiring Vigil Neuroscience and its investigational Alzheimer’s disease (AD) drug for ...

Merck & Co – known as MSD outside the US and Canada – has shared promising results from a late-stage study of its anti-PD-1 ...

Merck & Co – known as MSD outside of the US and Canada – has announced that its Welireg (belzutifan) has been approved by the ...

‘Rise Up’ features UK spoken word poet and hip-hop artist Duke Al Durham, who also has aT1D, and is inspired by the artists’ ...

In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...